Class II · ModerateRecall completed
Lisinopril tablets
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot # T04483, T04484, Exp 2/18; T06028, Exp 4/18; T08423, Exp 5/18
Where it was soldU.S. Nationwide and Puerto Rico
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed tablet/capsule specification: missing break line on the 5mg tablet.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Accord Healthcare, Inc., Durham, NC 27703 |
| NDC | 16729-376-17 |
Show the full FDA record
| Full product label | Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-376-17 |
| Recalling firm | Accord Healthcare, Inc. |
| Distribution | U.S. Nationwide and Puerto Rico |
| Quantity | 12896 bottles |
| Recall initiated | 2016-12-20 |
| Report date | 2017-02-22 |
| Recall completed | 2017-08-02 |
| Recall number | D-0478-2017 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Durham NC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.